Tag: nasdaq:sgen

January 28, 2020

BMO Kicks Off Coverage of 4 Biotech Players

Four firms in the biotech space will now receive coverage from the investor research arm of Canadian bank BMO.
July 26, 2018

Seattle Genetics Reports Q2 Results, ADCETRIS Sales in Focus

Seattle Genetics reported its Q2 2018 financial results on Thursday. It expects to report top-line data in Q4 from the...
June 13, 2018

Seattle Genetics Announces First Patient Dosed in Phase 2 Trial of Tisotumab Vedotin

Seattle Genetics (Nasdaq:SGEN) announced dosing of the first patient in the phase 2 innovaTV 204 clinical trial evaluating the efficacy, safety...